Cargando…

Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy

Therapeutic antiangiogenesis strategies have demonstrated significant antitumor efficacy in ovarian cancer. Recently, RNA interference (RNAi) has come to be regarded as a promising technology for treatment of disease, especially cancer. In this study, vascular endothelial growth factor (VEGF)-small...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yijie, Wang, Xinran, Liu, Ting, Zhang, Ding Sheng-zi, Wang, Yunfei, Gu, Hongchen, Di, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386807/ https://www.ncbi.nlm.nih.gov/pubmed/25848273 http://dx.doi.org/10.2147/IJN.S78774

Ejemplares similares

Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment
por: Xie, Xiaowei, et al.
Publicado: (2023)

Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment
por: Wang, Dandan, et al.
Publicado: (2017)

Characterization of modified mesoporous silica nanoparticles as vectors for siRNA delivery
por: Slita, Anna, et al.
Publicado: (2018)

High-Capacity Mesoporous Silica Nanocarriers of siRNA for Applications in Retinal Delivery
por: Ultimo, Amelia, et al.
Publicado: (2023)

Cyclodextrin and Polyethylenimine Functionalized Mesoporous Silica Nanoparticles for Delivery of siRNA Cancer Therapeutics
por: Shen, Jianliang, et al.
Publicado: (2014)

Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery
por: Ngamcherdtrakul, Worapol, et al.
Publicado: (2018)

Hypertension and Antiangiogenesis: The Janus Face of VEGF Inhibitors
por: Touyz, Rhian M., et al.
Publicado: (2019)

Biofunctionalized Decellularized Tissue-Engineered Heart Valve with Mesoporous Silica Nanoparticles for Controlled Release of VEGF and RunX2-siRNA against Calcification
por: Yu, Wenpeng, et al.
Publicado: (2023)

Mesoporous silica-coated silver nanoparticles as ciprofloxacin/siRNA carriers for accelerated infected wound healing
por: Liu, Qiqi, et al.
Publicado: (2022)

Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect
por: Chen, Mengchun, et al.
Publicado: (2019)

Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer
por: Watermann, Anna, et al.
Publicado: (2017)

Inhibition of retinal neovascularization by siRNA targeting VEGF(165)
por: Xia, Xiao-bo, et al.
Publicado: (2008)

Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer
por: Darvishi, Behrad, et al.
Publicado: (2017)

Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer
por: Zhuang, Jialang, et al.
Publicado: (2021)

siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells
por: Heidari, Razieh, et al.
Publicado: (2021)

Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum]
Publicado: (2021)

Overcoming the non-kinetic activity of EGFR1 using multi-functionalized mesoporous silica nanocarrier for in vitro delivery of siRNA
por: Parnian, Javad, et al.
Publicado: (2022)

Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery
por: Prabhakar, Neeraj, et al.
Publicado: (2016)

Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction]
Publicado: (2022)

Intraocular siRNA Delivery Mediated by Penetratin Derivative to Silence Orthotopic Retinoblastoma Gene
por: Gao, Xin, et al.
Publicado: (2023)

The application of mesoporous silica nanoparticles as a drug delivery vehicle in oral disease treatment
por: Fang, Lixin, et al.
Publicado: (2023)

Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy
por: Shahidi, Maryamsadat, et al.
Publicado: (2022)

Amphiphilic Polypeptides for VEGF siRNA Delivery into Retinal Epithelial Cells
por: Osipova, Olga, et al.
Publicado: (2020)

Effectiveness of Diverse Mesoporous Silica Nanoparticles as Potent Vehicles for the Drug L-DOPA
por: Swar, Sumita, et al.
Publicado: (2019)

Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF
por: Im, S-A, et al.
Publicado: (2001)

Cylindrical Microparticles Composed of Mesoporous Silica Nanoparticles for the Targeted Delivery of a Small Molecule and a Macromolecular Drug to the Lungs: Exemplified with Curcumin and siRNA
por: Fischer, Thorben, et al.
Publicado: (2021)

Co-delivery of VEGF siRNA and Etoposide for Enhanced Anti-angiogenesis and Anti-proliferation Effect via Multi-functional Nanoparticles for Orthotopic Non-Small Cell Lung Cancer Treatment
por: Li, Fang, et al.
Publicado: (2019)

Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells
por: Liu, Qian, et al.
Publicado: (2012)

Functionalized Folate-Modified Graphene Oxide/PEI siRNA Nanocomplexes for Targeted Ovarian Cancer Gene Therapy
por: Wang, Yunfei, et al.
Publicado: (2020)

Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy
por: Wan, Xueting, et al.
Publicado: (2021)

Monitoring antiangiogenesis of bevacizumab in zebrafish
por: Zhang, Jing, et al.
Publicado: (2018)

Redox-Sensitive Gelatin/Silica-Aptamer Nanogels for Targeted siRNA Delivery
por: Zhao, Xueqin, et al.
Publicado: (2019)

Strategies for Delivery of siRNAs to Ovarian Cancer Cells
por: Farra, Rossella, et al.
Publicado: (2019)

VEGF(121)-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System
por: Goel, Shreya, et al.
Publicado: (2014)

Dendritic Mesoporous Organosilica Nanoparticles with Photosensitizers for Cell Imaging, siRNA Delivery and Protein Loading
por: Omar, Haneen, et al.
Publicado: (2023)

Iodinated oil-loaded, fluorescent mesoporous silica-coated iron oxide nanoparticles for magnetic resonance imaging/computed tomography/fluorescence trimodal imaging
por: Xue, Sihan, et al.
Publicado: (2014)

Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route
por: Meryet-Figuière, Matthieu, et al.
Publicado: (2017)

Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA
por: Li, Jin-Ming, et al.
Publicado: (2013)

Efficient ocular delivery of siRNA via pH-sensitive vehicles for corneal neovascularization inhibition
por: Cao, Xiaowen, et al.
Publicado: (2023)

Surrogate markers in antiangiogenesis clinical trials
por: Davis, D W, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_t9rj3qrkbu1l3tvferj4oq3kqr